Manulife (Manufacturers Life Insurance)’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-39,378
| Closed | -$165K | – | 3130 |
|
|
2023
Q1 | $165K | Hold |
39,378
| – | – | ﹤0.01% | 2629 |
|
|
2022
Q4 | $237K | Buy |
39,378
+1,652
| +4% | +$9.02K | ﹤0.01% | 2451 |
|
|
2022
Q3 | $220K | Sell |
37,726
-888
| -2% | -$5.53K | ﹤0.01% | 2525 |
|
|
2022
Q2 | $231K | Buy |
+38,614
| New | +$198K | ﹤0.01% | 2558 |
|
|
2018
Q3 | – | Sell |
-47,439
| Closed | -$236K | – | 4317 |
|
|
2018
Q2 | $236K | Buy |
47,439
+44,795
| +1,694% | +$196K | ﹤0.01% | 3002 |
|
|
2018
Q1 | $10K | Hold |
2,644
| – | – | ﹤0.01% | 3937 |
|
|
2017
Q4 | $7K | Buy |
2,644
+2,346
| +787% | +$6.88K | ﹤0.01% | 4088 |
|
|
2017
Q3 | $1K | Sell |
298
-433
| -59% | -$1.45K | ﹤0.01% | 4225 |
|
|
2017
Q2 | $2K | Buy |
731
+188
| +35% | +$732 | ﹤0.01% | 4180 |
|
|
2017
Q1 | $2K | Buy |
+543
| New | +$2.51K | ﹤0.01% | 3994 |
|
|
2016
Q4 | – | Sell |
-544
| Closed | -$2K | – | 4586 |
|
|
2016
Q3 | $2K | Hold |
544
| – | – | ﹤0.01% | 4106 |
|
|
2016
Q2 | $2K | Sell |
544
-14,016
| -96% | -$64.3K | ﹤0.01% | 4061 |
|
|
2016
Q1 | $75K | Buy |
14,560
+3,167
| +28% | +$25.3K | ﹤0.01% | 3171 |
|
|
2015
Q4 | $141K | Buy |
11,393
+390
| +4% | +$5.21K | ﹤0.01% | 2915 |
|
|
2015
Q3 | $161K | Buy |
11,003
+267
| +2% | +$4.61K | ﹤0.01% | 2825 |
|
|
2015
Q2 | $209K | Buy |
10,736
+692
| +7% | +$13.4K | ﹤0.01% | 2813 |
|
|
2015
Q1 | $182K | Buy |
10,044
+346
| +4% | +$7.79K | ﹤0.01% | 2801 |
|
|
2014
Q4 | $229K | Buy |
9,698
+962
| +11% | +$22.2K | ﹤0.01% | 2555 |
|
|
2014
Q3 | $211K | Sell |
8,736
-85
| -1% | -$2.21K | ﹤0.01% | 2607 |
|
|
2014
Q2 | $248K | Sell |
8,821
-1,066
| -11% | -$32K | ﹤0.01% | 2565 |
|
|
2014
Q1 | $337K | Buy |
9,887
+618
| +7% | +$21.1K | ﹤0.01% | 2348 |
|
|
2013
Q4 | $178K | Sell |
9,269
-666
| -7% | -$12.1K | ﹤0.01% | 2793 |
|
|
2013
Q3 | $163K | Buy |
9,935
+112
| +1% | +$1.3K | ﹤0.01% | 2807 |
|
|
2013
Q2 | $103K | Buy |
+9,823
| New | +$115K | ﹤0.01% | 3002 |
|
Other funds holding CTIC
Manulife (Manufacturers Life Insurance)'s CTIC Position: Q2 2023 in Review
Manulife (Manufacturers Life Insurance) sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 39,378 shares — an estimated $165K sold.
Manulife (Manufacturers Life Insurance) first reported a position in CTIC in Q2 2013 and held it in 24 quarters. The position peaked at $337K in Q1 2014. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.
- Manulife (Manufacturers Life Insurance) reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 39,378 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $165K.
- Manulife (Manufacturers Life Insurance) first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 24 quarters.
- Manulife (Manufacturers Life Insurance)'s CTI BioPharma Corp. (DE) Common Stock position peaked at $337K in Q1 2014.
- 2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2023, filed 11 Aug 2023.